NCT02045017 2021-08-27
Efficacy and Safety of Pomalidomide and Dexamethasone in RRMM Patients With Renal Insufficiency
Celgene
Phase 2 Completed
Celgene
GlaxoSmithKline
Novartis
GlaxoSmithKline
GlaxoSmithKline
Point Therapeutics
Point Therapeutics
Point Therapeutics